Fresh analysis reveals that individuals who stop using popular slimming jabs like semaglutide or tirzepatide may regain lost weight far faster than those who end conventional lifestyle programs.
Research printed in a prominent health publication points out that while obese people can lose substantial amounts of their body weight while using the jabs, the mass comes back at an average rate of nearly a kilo each month once they quit.
"Users buying these treatments should be informed of the danger of fast weight regain when the medication ends," stated expert Dr. Susan Jebb.
This pace of regain implies a reversion to original weight within about a year and a half.
Analyzing Therapies
The research, which looked at 37 of studies involving thousands of patients, contrasted the results of GLP-1 agonists with conventional dieting.
Scientists point out that individuals who shed pounds through diet and exercise usually experience a slower creep back—perhaps 100 grams monthly—after stopping.
Explaining the Quick Rebound
Experts suggest the mode of action of the drugs explains the amplified rebound.
GLP-1 drugs imitate a natural hormone called GLP-1, which helps regulate feelings of fullness.
"Artificially providing the hormone concentrations several times higher than normal could lead to the system to generate a reduced amount of its own natural hormone, and may also diminish sensitivity to its effects," noted Dr. Adam Collins, a dietetics expert.
"Withdrawal of this hormone supplement leads to hunger is uncontrolled, making binge eating much more probable."
An Ongoing Issue?
Medical guidelines suggest the injections for individuals with obesity-related medical conditions, alongside prescribed lifestyle changes.
A number of clinicians say that, considering the significant potential of weight regain, the treatment might need to be life-long.
This opinion is supported by pharmaceutical companies, who say that the results "highlight the persistent character of obesity," comparing it to managing diseases like high blood pressure.
Patient Experiences
People who have come off the medication report a sudden resurgence of cravings.
"It felt as if a trigger activating and I was suddenly ravenous," recalled one woman.
This challenge is exacerbated if individuals have not established sustainable lifestyle or habit changes during therapy.
Significant Adoption
Figures indicate that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with desire being substantial.
- Use is greater among women compared to men.
- The middle-aged demographic shows the highest level of interest.
- A large proportion obtain the medications through private healthcare rather than public health services.
In conclusion, clinicians emphasize that while the jabs are potent agents for shedding pounds, they are not a magic cure and lasting health benefits likely depends on ongoing lifestyle changes.
